After a US$8 million seed round, Sydney startup Psylo is shipping its headquarters to the US. But there’s a reason why American co-founder and CEO Joshua Ismin is staying put.
Biotech
The WA startup is in the process of completing a small round to scale up its business ahead of a Series A before the end of the year.
Artificial intelligence systems are designed to mimic the way humans think. So why not recruit brain cells to help?
An Australian IVF pioneer and medtech leader have returned home to build a new biotech from the ground up, with a goal of fighting cancer. They have raised $30 million to date, and plan on raising another $20 million.
Founded in Melbourne, Synchron has inserted its brain implants into 10 human patients. Further along than Neuralink in clinical trials, it has attracted funding from Bill Gates and Jeff Bezos.
Ben Lamm’s ‘de-extinction’ company Colossal has been valued at US$1 billion. But what’s the business case for resurrecting extinct animals?
